Ghana's ambassador to the Kingdom visits Buraidah Dates Festival    Custodian of the Two Holy Mosques Congratulates President of the Republic of Hungary on Her Country's National Day    President of Uzbekistan Leaves Jeddah    HRH Crown Prince Receives Leader of Wisdom Movement in Iraq    Saudi National Team Player, Abdul-Elah Alem Becomes World Champion in Weight-less 62 KG MMA Competition    Uzbekistan's President and IsDB Discuss Boosting Bilateral Cooperation    Saudi Stock Exchange Main Index Ends Trading Lower at 12621.73 Points    Saudi Bowling Team Wins Silver Medal in Arab Championships in Cairo    Red Crescent air ambulance evacuates female Saudi patient from Georgia    SWCC Organizes Future of Desalination International Conference "FDIConf 2022" in Riyadh Next month    WHO chief says 'color of skin' behind lack of help for Tigray    Sri Lanka's economic crisis pushes health system to brink of collapse    WHO steps up assistance to flood-ravaged Yemen    21 killed, dozens hurt in explosion at Kabul mosque    Ammar Al-Hakim arrives in Jeddah    Al Rabeeah meets Omani twins Safa and Marwa 15 years after separation surgery    Amid singing, dancing and deep talk, Usyk and Joshua address pre-fight press conference Joshua wants to compete; Who doesn't compete doesn't live, says Usyk    Wildfires Kill at Least 26 in Eastern Algeria    "Disney on Ice" Characters Take Visitors to Boulevard Arena in Riyadh on an Extraordinary Journey    OIC Expresses Solidarity with Algeria over Forest Fires    Asian Stocks Fall    16 Dead, 36 Missing in Flash Flood in Western China    Crown Prince, Uzbek president hold talks in Jeddah    PIF buys stakes in Meta, Alphabet, Amazon, JPMorgan and other 13 companies    Saudi holdings of US treasury bonds rise by $4.5 billion in June    LuLu launches India Utsav    65 countries receive Unaizah dates    Usyk, Joshua conduct open training ahead of the biggest boxing event in Saudi Arabia    Saudi bowling team wins gold in doubles in Arab Championships in Cairo    Fifa suspends Indian FA over undue influence from third parties    Oscars apologizes to actress Sacheen Littlefeather after 50 years    Harry and Meghan to visit UK in September for charity events    Saudi Volleyball National Team to Face Zamalek Egyptian Team    Saudi Bowling Team Wins Gold in Doubles in Arab Championships in Cairo    J&J talc powder sold in Saudi Arabia does not contain asbestos: SFDA    King Salman Urban Charter's typeface wins three international prizes    Ka'aba door bears witness to Saudi rulers' care for the House of God Kaaba' door, repentance' door contain more than 280 KG of pure gold    How Aamir Khan adapted Forrest Gump to Bollywood Laal Singh Chaddha    Association of Culture and Arts in Dammam Announces Winners of "International Video Art Forum"    Slaughterhouses of MEWA received more than 600,000 sacrifices in 3 days of Eid    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    MoH Activates Sign Language to Communicate with Pilgrims with Deafness or Muteness During Hajj    Sheikh Al-Issa at Arafat sermon: Values of Islam foster harmony; eschew hatred and division    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Red Sea Fund Opens Its Third Cycle for Production Funding    SFDA Warns Against Herbal Product "Montalin Jamu" Due to Containing Active Medicinal Ingredients    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Oxford COVID-19 vaccine early trial shows positive result
Published in The Saudi Gazette on 20 - 07 - 2020

A coronavirus vaccine developed by Oxford University in the United Kingdom in collaboration with pharmaceutical giant AstraZeneca has produced a promising immune response in a large, early-stage human trial, according to newly released data published on Monday in the medical journal The Lancet.
Trials involving 1,077 people showed the injection led to them making antibodies and T-cells that can fight coronavirus.
The findings are hugely promising, but it is still too soon to know if this is enough to offer protection and larger trials are underway.
The researchers are calling their experimental vaccine ChAdOx1 nCoV-19 (AZD1222).
It is made from a genetically engineered virus that causes the common cold in chimpanzees.
It has been heavily modified, first so it cannot cause infections in people and also to make it "look" more like coronavirus.
Scientists did this by transferring the genetic instructions for the coronavirus' "spike protein" — the crucial tool it uses to invade our cells — to the vaccine they were developing.
This means the vaccine resembles the coronavirus and the immune system can learn how to attack it.
The UK has already ordered 100 million doses of the vaccine.
"The immune system has two ways of finding and attacking pathogens — antibody and T cell responses," Oxford Professor Andrew Pollard said in a release. "This vaccine is intended to induce both, so it can attack the virus when it's circulating in the body, as well as attacking infected cells. We hope this means the immune system will remember the virus, so that our vaccine will protect people for an extended period."
The potential vaccine by Oxford is one of at least 100 being developed across the world for coronavirus.
Last week, biotech firm Moderna released data on its potential coronavirus vaccine trial, saying it generated a "robust" immune response. That trial included 45 healthy participants and was run by the National Institutes of Health in the United States.
Earlier this month, pharmaceutical giant Pfizer, alongside German drugmaker BioNTech, released positive results from its closely watched early-stage human trial of a coronavirus vaccine. The company said its vaccine produced neutralizing antibodies in all participants who received two of the 10 or 30 microgram doses after 28 days, according to the preliminary data. — Agencies


Clic here to read the story from its source.